NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

It should be noted that even Roger Stupp officially stated in a presentation made in October, 2020, if I recall the approximate date correctly, that long term data provided in connection with Optune could not be relied upon because no follow up had been done. Accordingly, and in other words, Optune’s long term “data” could not be relied upon.

Dr. Stupp, as a PI in the Optune clinical trial, originally wrote the JA in NEJM as a lead author. Dr Stupp has since been a consultant for NWBO and has so acknowledged this relationship.